Nasdaq: ANGO

Angiodynamics Inc. (ANGO)

Angiodynamics Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker ANGO. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
ANGO
Exchange
Nasdaq
SEC CIK
1275187
Official filings
SEC EDGAR

Research ANGO

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Angiodynamics Inc.'s stock ticker?

Angiodynamics Inc. trades under the ticker symbol ANGO on Nasdaq. Its SEC Central Index Key (CIK) is 1275187.

Where can I read Angiodynamics Inc.'s SEC filings?

The ANGO SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Angiodynamics Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze ANGO's financial statements?

The ANGO Financials page shows Angiodynamics Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does ANGO compare with its peers and the market?

The ANGO Peer Comparison page lines Angiodynamics Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.